185 related articles for article (PubMed ID: 24123094)
21. Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids.
Stepan JJ; Havrdová E; Týblová M; Horáková D; Tichá V; Nováková I; Zikán V
Clin Chim Acta; 2004 Oct; 348(1-2):147-54. PubMed ID: 15369748
[TBL] [Abstract][Full Text] [Related]
22. Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis.
Dovio A; Perazzolo L; Osella G; Ventura M; Termine A; Milano E; Bertolotto A; Angeli A
J Clin Endocrinol Metab; 2004 Oct; 89(10):4923-8. PubMed ID: 15472186
[TBL] [Abstract][Full Text] [Related]
23. BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.
Koetz KR; van Rossum EF; Ventz M; Diederich S; Quinkler M
Clin Endocrinol (Oxf); 2013 Jun; 78(6):831-7. PubMed ID: 23134110
[TBL] [Abstract][Full Text] [Related]
24. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
[TBL] [Abstract][Full Text] [Related]
25. Higher hydrocortisone dose increases bilirubin in hypopituitary patients- results from an RCT.
Werumeus Buning J; Kootstra-Ros JE; Brummelman P; van den Berg G; van der Klauw M; Wolffenbuttel BH; van Beek AP; Dullaart RP
Eur J Clin Invest; 2016 May; 46(5):475-80. PubMed ID: 26999644
[TBL] [Abstract][Full Text] [Related]
26. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
27. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
Girgis R; Winter JS
J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
[TBL] [Abstract][Full Text] [Related]
28. Potassium Citrate Supplementation Decreases the Biochemical Markers of Bone Loss in a Group of Osteopenic Women: The Results of a Randomized, Double-Blind, Placebo-Controlled Pilot Study.
Granchi D; Caudarella R; Ripamonti C; Spinnato P; Bazzocchi A; Massa A; Baldini N
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30213095
[TBL] [Abstract][Full Text] [Related]
29. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
[TBL] [Abstract][Full Text] [Related]
30. Prospective follow-up of novel markers of bone turnover in persistent asthmatics exposed to low and high doses of inhaled ciclesonide over 12 months.
Anderson WJ; McFarlane LC; Lipworth BJ
J Clin Endocrinol Metab; 2012 Jun; 97(6):1929-36. PubMed ID: 22438232
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
32. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B
Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
[TBL] [Abstract][Full Text] [Related]
33. Cross-sectional evaluation of bone metabolism in men.
Szulc P; Garnero P; Munoz F; Marchand F; Delmas PD
J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833
[TBL] [Abstract][Full Text] [Related]
34. Acute Effects of Haloperidol, Amisulpride, and Quetiapine on Bone Turnover Markers in Patients With Schizophrenia.
Liang Y; Su YA; Zhao ZG; Gao N; Huang JZ; Tang MQ; Li KQ; Yang FD; Yu X; Si TM
J Clin Psychopharmacol; 2015 Oct; 35(5):583-6. PubMed ID: 26270200
[TBL] [Abstract][Full Text] [Related]
35. Effect of acute citrate load on markers of bone metabolism in healthy volunteers.
Chen Y; Bieglmayer C; Höcker P; Dettke M
Vox Sang; 2009 Nov; 97(4):324-9. PubMed ID: 19508702
[TBL] [Abstract][Full Text] [Related]
36. Clonidine increases bone resorption in humans.
Limonard EJ; Schoenmaker T; de Vries TJ; Tanck MW; Heijboer AC; Endert E; Fliers E; Everts V; Bisschop PH
Osteoporos Int; 2016 Mar; 27(3):1063-1071. PubMed ID: 26439240
[TBL] [Abstract][Full Text] [Related]
37. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
[TBL] [Abstract][Full Text] [Related]
38. Activity or mass concentration of bone-specific alkaline phosphatase as a marker of bone formation.
Avbersek-Luznik I; Gmeiner Stopar T; Marc J
Clin Chem Lab Med; 2007; 45(8):1014-8. PubMed ID: 17579570
[TBL] [Abstract][Full Text] [Related]
39. The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients.
Filipsson H; Monson JP; Koltowska-Häggström M; Mattsson A; Johannsson G
J Clin Endocrinol Metab; 2006 Oct; 91(10):3954-61. PubMed ID: 16895963
[TBL] [Abstract][Full Text] [Related]
40. The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers.
Athimulam S; Delivanis D; Thomas M; Young WF; Khosla S; Drake MT; Bancos I
J Clin Endocrinol Metab; 2020 May; 105(5):1469-77. PubMed ID: 32154561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
